Immune cell exclusion via encapsulation barrier

"Immune cell exclusion via encapsulation barrier" refers to the use of physical or biochemical barriers (such as encapsulating membranes or stromal layers) designed to prevent immune cells, antibodies, and other components of the immune system from accessing sensitive or transplanted cells, or, in the context of cancer, from infiltrating tumor compartments. In cell therapy (e.g., islet transplantation for diabetes), biomaterial encapsulation can create a selective barrier that allows small molecules (like oxygen, insulin, and glucose) to diffuse, while blocking immune cell or antibody penetration, thus protecting graft function. In tumors, a similar concept applies where stromal barriers formed by cancer-associated fibroblasts (CAF) and extracellular matrix (ECM) encapsulate tumor cells, thereby excluding immune cells and contributing to immune evasion and therapeutic resistance. Encapsulation barriers are not a single molecule or protein, but are created by either biomaterials (e.g., alginate hydrogels, synthetic polymers) in engineered settings, or by cells and matrix in physiological cancer or fibrotic states. This entry describes a functional mechanism, not a specific molecular target or druggable protein, and therefore does not fit established nomenclature for molecular targets or receptors.

Physical barrier preventing immune cell access. Local delivery of immunosuppressive drugs (in advanced encapsulation technologies).